873-80; discussion: 880-1.
233. Antoniou GA, Chalmers N, Georgiadis GS, Lazarides MK,
Antoniou SA, Serracino-Inglott F, et al. A meta-analysis of endovascular versus surgical reconstruction of femoropopliteal arterial disease.
J Vasc Surg 2013;57:242-53.
234. Acin F, de Haro J, Bleda S, Varela C, Esparza L. Primary nitinol
stenting in femoropopliteal occlusive disease: a meta-analysis of
randomized controlled trials. J Endovasc Ther 2012;19:585-95.
235. Katsanos K, Spiliopoulos S, Karunanithy N, Krokidis M, Sabharwal T,
Taylor P. Bayesian network meta-analysis of nitinol stents, covered
stents, drug-eluting stents, and drug-coated balloons in the femoropopliteal artery. J Vasc Surg 2014;59:1123-33 e8.
236. Brown J, Lethaby A, Maxwell H, Wawrzyniak AJ, Prins MH. Antiplatelet agents for preventing thrombosis after peripheral arterial
bypass surgery (review). The Cochran Collaboration 2011:1-32.
237. Belch JJ, Dormandy J, Biasi GM, Cairols M, Diehm C,
Eikelboom B, et al. Results of the randomized, placebo-controlled
clopidogrel and acetylsalicylic acid in bypass surgery for peripheral
arterial disease (CASPAR) trial. J Vasc Surg 2010;52:825-33. 833
e1-e2.
238. Sarac TP, Huber TS, Back MR, Ozaki CK, Carlton LM,
Flynn TC, et al. Warfarin improves the outcome of infrainguinal
vein bypass grafting at high risk for failure. J Vasc Surg 1998;28:
446-57.
239.